                </a></li></ul></div><p><strong>Figure 2.  <span>The relative amount of CML cells as a fuction of time, in patients treated with Imatinib.</span></strong></p><a id="article1.body1.sec2.sec1.fig2.caption1.p1" name="article1.body1.sec2.sec1.fig2.caption1.p1"></a><p>The circles represent experimental data replotted from (a) Michor et al <a href="#pone.0000990-Michor1">[30]</a> and (b) from Roeder et al <a href="#pone.0000990-Roeder1">[29]</a>; they show the median values of BCR-ABL transcripts (relative to BCR transcripts in (a) and ABL transcripts in (b)). The vertical bars are the quartiles. The solid lines represent the fitted theoretical curves, formula (7) of <a href="#pone.0000990.s001">Text S1</a>, obtained by a mean-square procedure. The estimated parameter values are: (a) d-l = 0.0502 days<sup>−1</sup>, β = 0.0065 days<sup>−1</sup>, α = 10<sup>−5</sup> days<sup>−1</sup>, J<sub>0</sub> = 0.47; (b) d-l = 0.0278 days<sup>−1</sup>, β = 0.0067 days<sup>−1</sup>, α = 0.0004 days<sup>−1</sup>, J<sub>0</sub> = 0.50. Here J<sub>0</sub> denotes the initial percentage of quiescent CML cells.</p>
